{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:00:14Z","timestamp":1789628414454,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Public Research Centre for Health (CRP-Sant\u00e9), Luxembourg","award":["20100708"],"award-info":[{"award-number":["20100708"]}]},{"name":"\u201cFonds National de la Recherche\u201d, Luxembourg","award":["AFR-3004509"],"award-info":[{"award-number":["AFR-3004509"]}]},{"name":"\u201cFonds National de la Recherche\u201d, Luxembourg","award":["CORE C11\/BM\/1209287"],"award-info":[{"award-number":["CORE C11\/BM\/1209287"]}]},{"name":"\u201cFonds National de la Recherche\u201d, Luxembourg","award":["CORE C09\/BM\/20"],"award-info":[{"award-number":["CORE C09\/BM\/20"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.bbamcr.2014.01.017","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T07:31:25Z","timestamp":1390807885000},"page":"1031-1041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection"],"prefix":"10.1016","volume":"1843","author":[{"given":"Andy","family":"Chevign\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fievez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Szpakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Counson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Pless\u00e9ria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Schmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Deroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2014.01.017_bb0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/33340","article-title":"Chemokines and leukocyte traffic","volume":"392","author":"Baggiolini","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","article-title":"Chemokines: multiple levels of leukocyte migration control","volume":"25","author":"Moser","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/84298","article-title":"Chemokines: immunology's high impact factors","volume":"2","author":"Mackay","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.185.1.111","article-title":"The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood","volume":"185","author":"Aiuti","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/31269","article-title":"Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development","volume":"393","author":"Zou","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0030","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood.V97.10.3283","article-title":"Rapid and efficient homing of human CD34+CD38\u2212\/lowCXCR4+ stem and progenitor cells to the bone marrow and spleen of NOD\/SCID and NOD\/SCID\/B2mnull mice","volume":"97","author":"Kollet","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/382635a0","article-title":"Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF\/SDF-1","volume":"382","author":"Nagasawa","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0040","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/31261","article-title":"The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract","volume":"393","author":"Tachibana","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0050","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0055","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.272.5263.872","article-title":"HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor","volume":"272","author":"Feng","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0065","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/ijc.22024","article-title":"Chemokines and cancer","volume":"119","author":"Zlotnik","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0070","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/infdis\/169.5.968","article-title":"The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression","volume":"169","author":"Richman","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0075","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","article-title":"CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1","volume":"272","author":"Alkhatib","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0080","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0092-8674(00)81313-6","article-title":"The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates","volume":"85","author":"Choe","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0090","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"issue":"Suppl. A","key":"10.1016\/j.bbamcr.2014.01.017_bb0095","first-page":"S3","article-title":"HIV entry and tropism: the chemokine receptor connection","volume":"11","author":"Berger","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/34571","article-title":"A new classification for HIV-1","volume":"391","author":"Berger","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0966-842X(02)02370-3","article-title":"Cell turnover and cell tropism in HIV-1 infection","volume":"10","author":"Davenport","year":"2002","journal-title":"Trends in microbiology"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0115","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/JVI.80.2.802-809.2006","article-title":"Naive and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy","volume":"80","author":"Ribeiro","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature03501","article-title":"Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection","volume":"434","author":"Mattapallil","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coi.2006.05.001","article-title":"Immunopathogenesis of acute AIDS virus infection","volume":"18","author":"Picker","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm1380","article-title":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys","volume":"12","author":"Grossman","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-4690-3-52","article-title":"Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission","volume":"3","author":"Groot","year":"2006","journal-title":"Retrovirology"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2003.10.003","article-title":"The significance of cancer cell expression of the chemokine receptor CXCR4","volume":"14","author":"Balkwill","year":"2004","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0145","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0150","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1158\/0008-5472.CAN-04-1343","article-title":"Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4","volume":"64","author":"Marchesi","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0155","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1126\/science.277.5332.1656","article-title":"A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus","volume":"277","author":"Kledal","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0160","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0165","doi-asserted-by":"crossref","first-page":"35760","DOI":"10.1074\/jbc.M508234200","article-title":"The chemokine SDF-1\/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes","volume":"280","author":"Balabanian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10555-010-9266-8","article-title":"CXCL12\/CXCR4\/CXCR7 chemokine axis and cancer progression","volume":"29","author":"Sun","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0175","doi-asserted-by":"crossref","first-page":"15735","DOI":"10.1073\/pnas.0610444104","article-title":"CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature","volume":"104","author":"Miao","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0180","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1002\/ijc.25245","article-title":"Overlapping and distinct role of CXCR7-SDF-1\/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas","author":"Grymula","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0185","first-page":"12","article-title":"CXCR7 impact on CXCL12 biology and disease","author":"Sanchez-Martin","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0190","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0195","doi-asserted-by":"crossref","first-page":"23736","DOI":"10.1074\/jbc.M000776200","article-title":"Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities","volume":"275","author":"Brelot","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0200","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1128\/JVI.73.4.2752-2761.1999","article-title":"Identification of CXCR4 domains that support coreceptor and chemokine receptor functions","volume":"73","author":"Doranz","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0205","doi-asserted-by":"crossref","first-page":"42826","DOI":"10.1074\/jbc.M106582200","article-title":"Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies","volume":"276","author":"Zhou","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.pharmtox.42.091901.115838","article-title":"Structure, function, and inhibition of chemokines","volume":"42","author":"Fernandez","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev.immunol.24.021605.090529","article-title":"Chemokine: receptor structure, interactions, and antagonism","volume":"25","author":"Allen","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0220","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1093\/emboj\/16.23.6996","article-title":"Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1","volume":"16","author":"Crump","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0225","doi-asserted-by":"crossref","first-page":"19084","DOI":"10.1074\/jbc.271.32.19084","article-title":"The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES\/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation","volume":"271","author":"Monteclaro","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0230","doi-asserted-by":"crossref","first-page":"1160755","DOI":"10.1126\/scisignal.1160755","article-title":"Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1\/CXCL12","volume":"1","author":"Veldkamp","year":"2008","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0235","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jmb.2004.11.003","article-title":"Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha","volume":"345","author":"Gozansky","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0240","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0960-9822(98)70155-1","article-title":"Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides","volume":"8","author":"Heveker","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0245","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.1074\/jbc.273.35.22279","article-title":"N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities","volume":"273","author":"Loetscher","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0250","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1021\/bi992750v","article-title":"A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II","volume":"39","author":"Zhou","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0255","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.bcp.2011.07.091","article-title":"Engineering and screening the N-terminus of chemokines for drug discovery","volume":"82","author":"Chevigne","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0260","doi-asserted-by":"crossref","first-page":"35240","DOI":"10.1074\/jbc.M109.024851","article-title":"Structural basis of the interaction between chemokine stromal cell-derived factor-1\/CXCL12 and its G-protein-coupled receptor CXCR4","volume":"284","author":"Kofuku","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0265","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1074\/jbc.M010429200","article-title":"Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor","volume":"276","author":"Gerlach","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(03)00824-X","article-title":"T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer","volume":"550","author":"Tamamura","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0275","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/bip.20653","article-title":"Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents","volume":"88","author":"Tsutsumi","year":"2007","journal-title":"Biopolymers"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0280","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1124\/mol.59.6.1418","article-title":"Pharmacological properties of peptides derived from stromal cell-derived factor 1: study on human polymorphonuclear cells","volume":"59","author":"Heveker","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0285","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jss.2008.06.044","article-title":"A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer","volume":"155","author":"Huang","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0290","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1124\/mol.108.053389","article-title":"AMD3100 is a CXCR7 ligand with allosteric agonist properties","volume":"75","author":"Kalatskaya","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0295","doi-asserted-by":"crossref","first-page":"24515","DOI":"10.1074\/jbc.M200889200","article-title":"A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pharmthera.2009.12.003","article-title":"Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications","volume":"126","author":"Galzi","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0305","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.bmcl.2004.02.091","article-title":"Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions","volume":"14","author":"Boussard","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0310","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1021\/ja1002263","article-title":"Targeting SDF-1\/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design","volume":"132","author":"Veldkamp","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0315","doi-asserted-by":"crossref","first-page":"23189","DOI":"10.1074\/jbc.M803947200","article-title":"Small neutralizing molecules to inhibit actions of the chemokine CXCL12","volume":"283","author":"Hachet-Haas","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0320","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection","volume":"91","author":"Wild","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0325","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1158\/1078-0432.CCR-13-0943","article-title":"Development and preclinical characterization of a humanized antibody targeting CXCL12","author":"Zhong","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0330","doi-asserted-by":"crossref","first-page":"25173","DOI":"10.1074\/jbc.M113.467969","article-title":"Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function","volume":"288","author":"Blanchetot","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0335","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.bcp.2012.08.008","article-title":"Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors","volume":"84","author":"Szpakowska","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0340","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-10-2636","article-title":"CXCL12 (SDF1\u03b1) \u2014 CXCR4\/CXCR7 pathway inhibition: an emerging sensitizer for anti-cancer therapies?","author":"Duda","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0345","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.molimm.2007.09.001","article-title":"Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitope","volume":"45","author":"Deroo","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0350","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1128\/JVI.73.11.8966-8974.1999","article-title":"A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor","volume":"73","author":"Trkola","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0355","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.2992081","article-title":"Infection of HTLV-III\/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay","volume":"229","author":"Harada","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0360","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1074\/jbc.271.1.225","article-title":"CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct","volume":"271","author":"Ahuja","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0365","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0370","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0166-0934(87)90002-4","article-title":"Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus","volume":"16","author":"Pauwels","year":"1987","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0375","doi-asserted-by":"crossref","first-page":"e60566","DOI":"10.1371\/journal.pone.0060566","article-title":"HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRRF01_AE and CRF02_AG","volume":"8","author":"Mulinge","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0380","doi-asserted-by":"crossref","first-page":"e21535","DOI":"10.1371\/journal.pone.0021535","article-title":"Impact of the HIV-1 env genetic context outside HR1\u2013HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates","volume":"6","author":"Baatz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0385","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1128\/JVI.01620-06","article-title":"Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages","volume":"81","author":"Perez-Bercoff","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0390","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(00)23372-7","article-title":"Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with BIACORE","volume":"323","author":"Myszka","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0395","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2003-08-2669","article-title":"Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5","volume":"103","author":"Agrawal","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0400","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1128\/JVI.73.8.6598-6609.1999","article-title":"Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates","volume":"73","author":"Chabot","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0405","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1002\/chem.201200111","article-title":"A functionally selective synthetic mimic of the HIV-1 co-receptor CXCR4","volume":"18","author":"Mobius","year":"2012","journal-title":"Chemistry"},{"issue":"10","key":"10.1016\/j.bbamcr.2014.01.017_bb0410","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/cmdc.201300289","article-title":"Anti-HIV-1 peptide derivatives based on the HIV-1 co-receptor CXCR4","volume":"8","author":"Hashimoto","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0415","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1128\/JVI.73.4.2576-2586.1999","article-title":"Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses","volume":"73","author":"Brelot","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0420","doi-asserted-by":"crossref","first-page":"15076","DOI":"10.1074\/jbc.M111.332361","article-title":"Peptides from second extracellular loop of C\u2013C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1","volume":"287","author":"Dogo-Isonagie","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0425","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1128\/JVI.76.17.8953-8957.2002","article-title":"The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor","volume":"76","author":"Cormier","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0430","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/JVI.71.6.4744-4751.1997","article-title":"Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity","volume":"71","author":"Brelot","year":"1997","journal-title":"J. Virol."},{"issue":"Pt 7","key":"10.1016\/j.bbamcr.2014.01.017_bb0435","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1099\/0022-1317-79-7-1793","article-title":"The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2","volume":"79","author":"Reeves","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0440","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1128\/JVI.72.8.6475-6481.1998","article-title":"The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus","volume":"72","author":"Willett","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0445","article-title":"Structure prediction of GPCRs using piecewise homologs and application to the human CCR5 chemokine receptor: validation through agonist and antagonist docking","author":"Arumugam","year":"2013","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0450","doi-asserted-by":"crossref","first-page":"17655","DOI":"10.1073\/pnas.1101133108","article-title":"Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways","volume":"108","author":"Drury","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0455","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1074\/jbc.M707465200","article-title":"The role of CXCR7\/RDC1 as a chemokine receptor for CXCL12\/SDF-1 in prostate cancer","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0460","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jso.21957","article-title":"Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma","volume":"104","author":"Gebauer","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0465","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3892\/etm.2012.631","article-title":"CXCL12\/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: a clinical study","volume":"4","author":"Zhong","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0470","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jmb.2006.04.052","article-title":"Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha\/CXCL12)","volume":"359","author":"Veldkamp","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0475","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.chembiol.2012.10.007","article-title":"Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides","volume":"19","author":"Secchi","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbamcr.2014.01.017_bb0480","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1096\/fj.10-167627","article-title":"Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity","volume":"25","author":"Lusso","year":"2011","journal-title":"FASEB J."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488914000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488914000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:24:15Z","timestamp":1716485055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488914000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0167488914000299"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2014.01.017","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2014.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}